CAMBRIDGE, Mass., Sept. 21, 2017 --
What: The seventh annual Pega Collaborative Healthcare Summit, hosted by Pegasystems Inc., will bring together leaders in healthcare, insurance, life sciences, and government to focus on the biggest issues, challenges, and opportunities facing the healthcare industry today.
When: Sunday, October 1 – Tuesday, October 3, 2017
Where: The Westin Copley Place, Boston, 10 Huntington Ave., Boston, Massachusetts
Who: More than 400 healthcare and technology thought leaders from over 70 leading healthcare and consulting organizations will gather at the Pega Collaborative Healthcare Summit to discuss technology and trends disrupting the industry. Keynotes and breakout sessions will focus on the impact of the digitally-focused healthcare customer, as well as the emergence of artificial intelligence (AI) and robotics as critical components that enable optimized customer journeys and outcomes across the healthcare ecosystem. At this year’s summit, attendees will hear from more than 30 industry experts and leaders including:
- Liat Ben-Zur, senior vice president, connected platforms, Philips
- Benjamin Durieux, head of ITS global solution center, integrated patient care & market access, Sanofi
- Keith Farley, director of innovation & customer experience, Aflac
- Julie Feirtag, associate vice president, customer service, UCare
- Mike Gromer, director, information technology, Anthem
- Tom Libretto, chief marketing officer and senior vice president, Pegasystems
- Jon Shreve, president & CEO, MCG Health
- Susan Taylor, vice president and business line leader, global healthcare and life sciences, Pegasystems
Attendees will also have the opportunity to experience live demos in the Tech Pavilion, as well as main stage demos. For more information, including a complete list of speakers and sessions or to register for the event, please visit the Pega Collaborative Healthcare Summit website at https://www.pega.com/events/healthcare-summit. Follow the conversation on Twitter with the hashtag #pegahc.
About Pegasystems
Pegasystems Inc. is the leader in software for customer engagement and operational excellence. Pega’s adaptive, cloud-architected software – built on its unified Pega® Platform – empowers people to rapidly deploy, and easily extend and change applications to meet strategic business needs. Over its 30-year history, Pega has delivered award-winning capabilities in CRM and BPM, powered by advanced artificial intelligence and robotic automation, to help the world’s leading brands achieve breakthrough business results. For more information on Pegasystems (NASDAQ:PEGA) visit www.pega.com.
Press Contact:
Ilena Ryan
Pegasystems Inc.
[email protected]
(617) 866-6722
Twitter: @pega
All trademarks are the property of their respective owners.


BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Italy Fines Apple €98.6 Million Over App Store Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



